Anti-Cancer Drug Discovery and Development


Evolution of drugs to selectively interfere with and slow down tumour growth has now entered a new and exciting era of the target orientated approach. Drugs are now being evolved against specific proteins included in cancer cell growth that have been uncovered over the last 10 years or so. The drug discovery operation is still a mixture of random screening and rational drug design. Relationships between academia and industry in drug discovery and development have continued to change over time as a result of technical and financial challenges and, most importantly, to the neutral of translating effective scientific discoveries into clinical opportunities.



 


    Related Conference of Anti-Cancer Drug Discovery and Development

    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France

    Anti-Cancer Drug Discovery and Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in